JasperYang

Associate

Shanghai + 86.21.2201.8029

Collegati

Condividi

Jasper Yang's practice focuses on cross-border mergers and acquisitions, foreign direct investment, cross-border financing, real estate, joint ventures, and other commercial transactions.

Jasper has provided professional legal services to a number of multinational companies in the chemical technology, biotechnology, and hi-tech industries. He has also advised foreign investors on general corporate issues relating to the incorporation of wholly foreign-owned enterprises (WFOEs), regulatory approval, and real estate developments.

Esperienze

  • Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.
  • Gaw Capital Partners enters strategic partnership with Sinar Primera in Indonesia data center developmentWorking with local Indonesian counsel, Jones Day advised Gaw Capital Partners regarding its entry into a strategic partnership with Sinar Primera, a leading Indonesian developer of new economy real estate, to develop an Internet Data Center at Nongsa Digital Park in Batam, Indonesia.
  • J.M. Huber acquires Biolchim GroupJones Day advised J. M. Huber Corporation in the acquisition of Biolchim Group, a leading producer and distributor of specialty plant nutrition and biostimulants, from private equity firms NB Renaissance and Chequers Capital and the Biolchim Group management team.
  • Albaugh acquires RotamJones Day advised Albaugh, LLC in the $197.5 acquisition of Rotam Global AgroSciences Limited, a company headquartered in Hong Kong and publicly listed on the Taiwan Stock Exchange.
  • Ulanqab Lamb Weston Food Co., Ltd. obtains RMB1.079 billion term loan facilityJones Day represented Ulanqab Lamb Weston Food Co., Ltd., a limited liability company incorporated under the laws of the People's Republic of China and a wholly-owned subsidiary of Lamb Weston Holdings, Inc., in connection with a RMB1.079 billion term loan facility provided by HSBC Bank (China) Company Limited, Shanghai Branch, as the facility agent, and its related capital investment in a new french fry processing facility in Ulanqab, Inner Mongolia.
  • Helios Technologies completes acquisition of assets of JoyonwayJones Day advised Helios Technologies, Inc. in the acquisition of assets related to the electronic control systems and parts business of Shenzhen Joyonway Electronics & Technology Co., Ltd and its related entities (collectively “Joyonway”).
  • Riverside portfolio company UniFocus acquires KnowcrossJones Day advised The Riverside Company in the acquisition by portfolio company, UniFocus, of Knowcross, a global leader in task management and operational optimization software for the hospitality industry.
  • Riverside and Investcorp sell Arrowhead Engineered Products to GenstarJones Day advised The Riverside Company in the sale of Arrowhead Engineered Products to Genstar.
  • TimkenSteel sells TimkenSteel (Shanghai) Corporation Limited to Daido SteelJones Day advised TimkenSteel Corporation in the sale of its TimkenSteel (Shanghai) Corporation Limited subsidiary in China to Daido Steel (Shanghai) Co., Ltd.
  • Major pharmaceutical company arbitrates claims arising out of Chinese investmentsJones Day is representing a major pharmaceutical company in a Hong Kong International Arbitration Centre arbitration arising out of representations and warranties given in respect of the client's investment in a Chinese drug development company whose senior officers and consultants were subsequently prosecuted in the United States for misappropriation of another pharmaceutical company's trade secrets.
    •

    JULY 2024 Commentary

    China's Revised Company Law Introduces Significant Changes for Foreign Investors

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.